Capital Performance Advisors »

Prelude Therapeutics shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $17 8 2.13

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Deerfield Management Company
Boxer Capital
T. Rowe Price Associates
BlackRock
BlackRock
Vanguard Group
ExodusPoint Capital Management
Avidity Partners Management
Massachusetts Financial Services
Geode Capital Management
Marshall Wace
Sio Capital Management
Morgan Stanley

View all funds holding Prelude Therapeutics